Germs

Germs

Early Stage

Top quality PPE products designed by Todd Goldman to put a smile on your face

Top quality PPE products designed by Todd Goldman to put a smile on your face

Overview

Raised to Date: Raised: $100,457

Total Commitments ($USD)

Platform

Wefunder

Start Date

05/18/2021

Close Date

11/18/2021

Min. Goal
$50,000
Max. Goal
$500,000
Min. Investment

$100

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Early Bird Valuation

$4,000,000

Pre-Money Valuation

$5,000,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

11/29/2021

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$549

# of Investors

48

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Consumer Products, Goods & Services

Tech Sector

Non-Tech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Location

Marina del Rey, California

Business Type

Life Style

Germs, with a pre-money valuation of $5 million, is raising funds on Wefunder. The company makes and sells hand sanitizers, masks, and other PPE products during the coronavirus pandemic. The PPE products of Germs are designed by the world-famous artist Todd Goldman and bring smiles to sanitation. Hayden Michael founded Germs in March 2021. The current crowdfunding round of the company has a minimum target of $50,000 and a maximum target of $500,000. The raise proceeds will target product development, sales and marketing, wages and salaries, and other costs. Germs has a national representation deal with Diverse Marketing, leading to its positioning in over 10,000 gift stores.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-249

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,000

$0

Accounts Receivable

$1,199

$0

Total Assets

$1,000

$0

Short-Term Debt

$1,199

$0

Long-Term Debt

$0

$0

Total Liabilities

$1,199

$0

Financials as of: 05/18/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Germs on Wefunder
Platform: Wefunder
Security Type: Equity - Common
Valuation: $5,000,000
Price per Share: $1.00

Follow company

Follow Germs on Wefunder

Buy Germs's Deal Report

Warning: according to the close date for this deal, Germs may no longer be accepting investments.

Germs Deal Report

Get KingsCrowd’s comprehensive report on Germs including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Germs is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Germs deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge